All In Biotech

Drug Trial Radar · NCT06921785

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

A Phase III, Randomised, Open-label, Sponsor-blinded, Multicentre Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,220 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,220

Planned (sponsor's estimate)

Start

May 6, 2025

Primary completion

Mar 15, 2030

Study completion Mar 15, 2030

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Apr 10, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase III, randomised, open-label, sponsor-blinded, 3-arm, multicentre, global study assessing the efficacy and safety of rilvegostomig in combination with bevacizumab with or without tremelimumab compared to atezolizumab in combination with bevacizumab. This study will be conducted in participants with advanced HCC who are not amenable to curative therapy or locoregional therapy

Conditions

  • Hepatocellular Carcinoma

Interventions

  • TremelimumabDrug

    IV therapy

  • RilvegostomigDrug

    IV therapy

  • BevacizumabDrug

    IV therapy

  • AtezolizumabDrug

    IV therapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To demonstrate the efficacy of Arm A relative to Arm C by assessment of OS in participants with advanced HCCTime frame: Up to approximately 6 years

Locations

226 sites in 20 countries. Site status is shown where the registry gives one.

  • Research Site

    Phoenix, Arizona · Recruiting

  • Research Site

    Tucson, Arizona · Recruiting

  • Research Site

    Los Angeles, California · Recruiting

  • Research Site

    Palo Alto, California · Recruiting

  • Research Site

    Denver, Colorado · Not yet recruiting

  • Research Site

    New Haven, Connecticut · Recruiting

  • Research Site

    Newark, Delaware · Recruiting

  • Research Site

    Jacksonville, Florida · Recruiting

  • Research Site

    Orlando, Florida · Not yet recruiting

  • Research Site

    Atlanta, Georgia · Recruiting

  • Research Site

    Atlanta, Georgia · Withdrawn

  • Research Site

    Honolulu, Hawaii · Withdrawn

  • Research Site

    Chicago, Illinois · Recruiting

  • Research Site

    Indianapolis, Indiana · Not yet recruiting

  • Research Site

    Shreveport, Louisiana · Not yet recruiting

  • Research Site

    Detroit, Michigan · Recruiting

  • Research Site

    Grand Rapids, Michigan · Recruiting

  • Research Site

    Rochester, Minnesota · Recruiting

  • Research Site

    St Louis, Missouri · Not yet recruiting

  • Research Site

    New Brunswick, New Jersey · Recruiting

  • Research Site

    New York, New York · Recruiting

  • Research Site

    New York, New York · Recruiting

  • Research Site

    New York, New York · Not yet recruiting

  • Research Site

    Cleveland, Ohio · Withdrawn

  • Research Site

    Oklahoma City, Oklahoma · Not yet recruiting

  • Research Site

    Philadelphia, Pennsylvania · Not yet recruiting

  • Research Site

    Pittsburgh, Pennsylvania · Recruiting

  • Research Site

    Amarillo, Texas · Recruiting

  • Research Site

    Austin, Texas · Recruiting

  • Research Site

    Dallas, Texas · Withdrawn

  • Research Site

    Houston, Texas · Recruiting

  • Research Site

    San Antonio, Texas · Recruiting

  • Research Site

    Tyler, Texas · Recruiting

  • Research Site

    Arlington, Virginia · Recruiting

  • Research Site

    Salem, Virginia · Recruiting

  • Research Site

    Seattle, Washington · Recruiting

  • Research Site

    Milwaukee, Wisconsin · Recruiting

  • Research Site

    Camperdown, Australia · Recruiting

  • Research Site

    Clayton, Australia · Recruiting

  • Research Site

    Heidelberg, Australia · Recruiting

Showing 40 of 226 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.